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DOI 10.1016/j.stem.2008.07.018Although the use of citations to develop
data sets for analysis has a lengthy
history, Lo¨ser et al. (2008) are correct
to point out—as I acknowledged—that
these data sets are inherently noisy. In
this case, I made a deliberate choice to
use citation linkages to define my data
sets because of the opportunity these
linkages offered to use an identical meth-
odology to develop data sets not just for
hESC- and RNAi-related research but
also for research related to 50 other influ-
ential biomedical research articles. In my
view, this ability to make comparisons be-
tween fields and countries outweighed
the loss of precision present in hand-col-
lated data sets in previous studies (Guhr
et al., 2006; Owen-Smith and McCormick,
2006).
I did not claim, nor intend to imply, that
my data set consisted entirely of experi-
mental work involving hESCs. Rather,
throughout my paper, and indeed in its ti-
tle, I referred to my data sets as research
related to hESCs and RNAi, and I clearly
articulated the importance of this phras-
ing. This distinction is not mere seman-
tics. Many of the non-hESC articles
included in my hESC-related data set re-
port primary research using embryonic
stem cells in animal models or other
human stem cells. I do not consider these
articles false positives. Many important
advances in hESC science have been
based on just this sort of related research.
Furthermore, scientists starting hESC re-
search programs may opt to work with
mouse cells initially and transition to
hESCs over time. Although not all articles
in related fields cite the initial hESC article,
I believe those that do are disproportion-
ately likely to report relevant work. My
data set also includes some review mate-
rial that summarizes existing research or
introduces hESC science to related fields.
Though not primary research, these arti-
cles serve an important scientific pur-
pose, clearly related to hESC science.I do agree that articles on the ethical and
legal implications of hESC research are
false positives. Due to time limitations,
I chose not to manually review each of
22,000 articles in my three data sets to
systematically remove these articles.
A preliminary search of the titles of articles
in my hESC-related set for keywords rel-
evant to ethical, legal, and policy issues
identified 24 papers (2%) divided
among nine countries. Excluding these
articles has essentially no impact on
my identification of over- and underper-
forming countries in research related to
hESCs.
Lo¨ser et al.’s letter highlights a point
that should have, in retrospect, been
drawn out more clearly. The inclusion of
research related to, but not explicitly us-
ing, hESCs into my data set reduced the
magnitude of the signal my study aimed
to detect because the distribution of this
related research is more likely to mirror
the control set. The conservative nature
of this signal means my approach will
tend to underestimate the magnitude of
underperformance in countries, such as
Germany, France, and Japan, that have
relatively strong developmental biology
research communities.
If anything, given the different method-
ologies, I interpret Lo¨ser et al.’s analysis
as confirmatory rather than contradictory.
Indeed, if their data on country shares of
experimental hESC research are com-
pared to my biomedical control set, the
set of seven overperforming countries
are the same, as are four of the top five
underperforming countries (the only
change is the substitution of Germany
for Switzerland). Thus, although the order
of the countries and the magnitude of the
under- and overperformance differs, both
analyses paint broadly similar pictures of
the development of this field.
Incorporating measures of research
quality would be an interesting extension
to my analysis of country-level researchCell Stem Ceoutput. However, because citation distri-
butions are skewed to the point that a
journal’s impact factor is not particularly
representative of any individual article
(Garfield, 2006; Seglen, 1997), country-
level weighted average journal impact
factors may not be an appropriate strat-
egy to accomplish this task. Furthermore,
the journal selection and publication
process is influenced by social as well
as scientific factors, particularly given
the single-blind review system common
in the life sciences. Lo¨ser et al. should
not discount the possibility that the differ-
ences they find reflect, in part, the social
structure of science that may make it
easier for western and English-speaking
scientists to gain access to high-impact
journals (Link, 1998; Ross et al., 2006).
I commend Lo¨ser et al. for their efforts
developing a verified data set of con-
firmed experimental hESC articles—a
hugely valuable resource. Policy analysis
is most effective when it builds upon mul-
tiple data sources, and I believe both ap-
proaches can contribute to the growing
understanding of the influence of public
policy on the development of hESC and
related research.
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